SALIVARY CANCER
Clinical trials for SALIVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY CANCER trials appear
Sign up with your email to follow new studies for SALIVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a prostate cancer drug shrink salivary tumors?
Disease control OngoingThis study tests enzalutamide, a drug already approved for other cancers, in 46 people with a specific type of salivary gland cancer that has androgen receptors. The goal is to see if the drug can shrink tumors by at least 30% in 1 out of 5 patients. Researchers will also track h…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Keytruda takes on 15 advanced cancers in major trial
Disease control OngoingThis phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in people with 15 types of advanced solid tumors that have worsened after standard treatments. About 1,600 participants receive the drug to see if their tumors shrink or stop growing. The study also looks fo…
Matched conditions: SALIVARY CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC